(Total Views: 387)
Posted On: 12/20/2022 11:15:52 AM
Post# of 69

$ALT News Article - Altimmune Announces Positive Topline Results from 24-Week (12-Week Extension) Trial of Pemvidutide in Subjects with Non-Alcoholic Fatty Liver Disease (NAFLD) https://marketwirenews.com/news-releases/alti...40773.html


My Twitter: WhyteStocks